Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,575.83
(
-0.74%
)
US TECH 100
23,615.20
(
-0.76%
)
Dow Jones
45,802.76
(
-0.91%
)
Brent Oil
105.66
(
-0.87%
)
Bitcoin
69,705.47
(
-2.16%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Double_Bagel post# 190770

Thursday, 10/29/2015 9:00:34 AM

Thursday, October 29, 2015 9:00:34 AM

Post# of 257259
(MNTA)—TEVA reports $878M of 3Q15 US Copaxone sales (+1% vs 2Q15); 40mg Copaxone comprised for 76% of overall Copaxone volume in Sep 2015, according to IMS:

http://finance.yahoo.com/news/teva-reports-third-quarter-2015-110000283.html

NVS did not disclose 3Q15 Glatopa sales. MNTA reports 3Q15 financial results on 11/4/15.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now